Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Europe remains the priciest of the four pregabalin markets tracked here on the back of strict regulatory compliance and quality-audit costs, up 4.6% in Q2 2026 to USD 61.90/kg from USD 59.20/kg in Q1. China's story is more interesting: after eroding steadily through 2025 on rising generic competition, prices there reversed hard, jumping 9.2% to USD 40.20/kg once an environmental-compliance shutdown at a key intermediate producer tightened feedstock availability. Across all four regions, the global average rose from USD 47.60/kg to USD 50.35/kg - a 5.8% gain, and the second straight quarter of recovery after four consecutive quarters of decline through 2025. Pregabalin is an anticonvulsant and analgesic API used to treat neuropathic pain, fibromyalgia, epilepsy, and generalized anxiety disorder. Getting there is not a quick process - the multi-step synthesis route depends on a fairly small number of specialised chiral-resolution and cyanide-based intermediates, and only a concentrated handful of manufacturers actually make them. What moves this market most: how fast generic manufacturers can qualify new capacity, how available the key intermediates are, how strictly environmental-compliance rules get enforced, and regulatory audit costs.
Firmness looks like the more likely path through the second half of 2026. Chinese intermediate supply should stay constrained while the affected producer works through the remediation required to resume compliant operations. India's pricing should track the broader recovery too, though probably at a more moderate pace given the country's own expanding intermediate capacity is working against it somewhat. Europe should keep its lead as the priciest market - nothing suggests regulatory audit or compliance costs are about to ease there. The US should keep tracking the recovery on steady generic-formulation demand. Unless the Chinese compliance issue resolves faster than expected, gradual is the more realistic word for the rest of the year.
If the remediation timeline at the affected Chinese producer drags on and generic-formulation demand rebounds harder than expected, prices could push toward the top of the ranges below. On the other hand, a faster-than-expected resumption of compliant Chinese output alongside renewed Indian capacity additions could pull the global average back down - and potentially resume the erosion pattern seen through most of 2025.
| Region | 2026 Price Range (USD/kg) | Outlook |
| Global Average | 48.00 - 55.00 | Recovery continues on constrained intermediate supply, though pace may moderate |
| India | 40.00 - 46.00 | Moderate recovery tempered by expanding domestic intermediate capacity |
| China | 38.00 - 45.00 | Compliance remediation timeline keeps intermediate supply constrained |
| United States | 56.00 - 62.00 | Steady generic-formulation demand supports continued gradual recovery |
| Europe | 60.00 - 66.00 | Regulatory audit and quality-compliance costs sustain a regional premium |
Indian pregabalin prices climbed 6.1% in Q2 2026, from USD 39.10/kg to USD 41.50/kg, as domestic formulators found themselves competing harder for key intermediate volumes once a slice of the usual Chinese supply got diverted to cover that country's own shortfall. Export demand from Latin American and Southeast Asian generic manufacturers stayed firm too, adding further support.
Why did the price of Pregabalin change in Q2 2026 in India?
The scramble for intermediate material got worse as Chinese supply tightened further - Indian formulators had to pay more for volumes that would ordinarily have flowed easily. Firm export orders from other generic manufacturers reinforced the move on top of that. Producers with their own backward-integrated intermediate capacity fared noticeably better this quarter than those still relying on imports.
No market moved more than China this quarter - prices jumped 9.2% to USD 40.20/kg from USD 36.80/kg in Q1. An environmental-compliance shutdown at a key intermediate producer stretched into a second quarter with still no confirmed restart date. Buyers scrambled to lock down remaining inventory, and spot premiums widened noticeably as downstream formulators worked through whatever safety stock they'd built up earlier in the year.
Why did the price of Pregabalin change in Q2 2026 in China?
The extended shutdown at a major intermediate producer took a significant volume of feedstock off the market for a second straight quarter, and with no restart date in sight, downstream formulators kept bidding up whatever remaining inventory was available - that combination explains the steepest quarterly move in this report.
US prices rose 4.5% in Q2 2026, from USD 55.30/kg to USD 57.80/kg, extending the recovery that started earlier in the year after four straight quarters of decline through 2025. Imported-intermediate costs from Asia kept rising as Chinese supply stayed constrained, generic-formulation demand held steady, and regulatory filing and testing costs added a modest layer on top.
Why did the price of Pregabalin change in Q2 2026 in the United States?
Rising costs on imported key intermediates flowed straight through to formulator pricing as Chinese supply stayed tight, and with generic-formulation demand steady there wasn't much pulling prices the other way. Regulatory testing costs piled a bit more on top. This recovery simply extended what started the prior quarter.
Europe held its position as the costliest market, up 4.6% to USD 61.90/kg from USD 59.20/kg in Q1. Strict quality-audit and regulatory-compliance requirements kept the regional premium firmly in place, and a weaker euro against the dollar made imported intermediate material pricier still.
Why did the price of Pregabalin change in Q2 2026 in Europe?
Regulatory audit and quality-compliance costs have kept European production economics structurally higher for a while now, and this quarter a weaker euro pushed the cost of imported intermediate material up further on top. Formulators, unsurprisingly, passed that added cost through to buyers rather than absorb it.
Indian prices rose 2.4% in Q1 2026 to USD 39.10/kg from USD 38.20/kg in Q4 2025 - the first quarterly increase after four straight quarters of decline. Early signs of tightening Chinese intermediate supply prompted formulators to start securing material ahead of an anticipated shortfall, though continued domestic capacity additions kept the increase modest.
Why did the price of Pregabalin change in Q1 2026 in India?
Early signals of tightening Chinese intermediate supply pushed formulators to secure material ahead of an anticipated shortfall, ending four straight quarters of decline - though ongoing domestic capacity additions kept the increase from accelerating much further. This turned out to be just the first stage of a recovery that picked up real momentum the following quarter.
Chinese prices rose 7.3% in Q1 2026, to USD 36.80/kg from USD 34.30/kg in Q4 2025 - the first increase after a sustained decline through 2025. Partway through the quarter, an environmental-compliance shutdown hit a key intermediate producer, removing meaningful feedstock volume from the market. Buyers accustomed to ample availability moved quickly once the shutdown was announced.
Why did the price of Pregabalin change in Q1 2026 in China?
An environmental-compliance shutdown at a major intermediate producer, announced partway through the quarter, took a meaningful volume of feedstock off the market right as buyers who'd grown used to ample supply rushed to secure what remained - that ended a decline that had run through all of 2025, and set up the sharper move that followed in Q2.
US prices rose 2.2% in Q1 2026 to USD 55.30/kg from USD 54.10/kg in Q4 2025 - the first increase after a steady decline through the prior year - as early signs of Chinese intermediate tightness started feeding into imported-material costs. Generic-formulation demand held steady, giving the modest cost-driven increase a stable base to build on.
Why did the price of Pregabalin change in Q1 2026 in the United States?
Early indications of tightening Chinese intermediate supply began feeding through to imported-material costs, ending a steady decline that had run through the prior year, while stable generic-formulation demand gave the move a consistent base to build on. This was really just the opening stage of the sharper recovery that showed up in Q2.
European prices rose 2.2% in Q1 2026 to USD 59.20/kg from USD 57.90/kg in Q4 2025 - the first increase after a sustained decline through 2025 - as rising imported-intermediate costs tied to emerging Chinese supply tightness started to outweigh the downward pull from generic competition. Regulatory compliance costs stayed a persistent structural factor sustaining the region's premium through the reversal.
Why did the price of Pregabalin change in Q1 2026 in Europe?
Rising imported-intermediate costs, tied to emerging tightness in Chinese supply, began outweighing the downward pull that generic competition had exerted through 2025, ending the decline. Persistent regulatory compliance costs kept sustaining the region's structural premium underneath it all. The reversal gathered more momentum the following quarter.
Global pregabalin prices eroded steadily through 2025, falling from USD 48.88/kg in Q2 2025 to USD 46.13/kg by Q4 as expanding generic manufacturing capacity - particularly in India - pressured pricing across every region tracked. That trend reversed in early 2026: prices climbed to USD 47.60/kg in Q1, then USD 50.35/kg by Q2, as an environmental-compliance shutdown at a key Chinese intermediate producer tightened feedstock supply and pushed the global average back above where it stood a year earlier.
| Quarter | Price (USD/kg) | QoQ Change | Direction |
| Q2 2026 | 50.35 | +5.8% | ↑ Rising |
| Q1 2026 | 47.60 | +3.2% | ↑ Rising |
| Q4 2025 | 46.13 | -2.9% | ↓ Falling |
| Q3 2025 | 47.53 | -2.8% | ↓ Falling |
| Q2 2025 | 48.88 | - | --- Stable |
| Q3 2026 | In Progress | - | --- In Progress |
2025 was a year of steady erosion for pregabalin - every region tracked posted an annual decline as expanding generic manufacturing capacity, particularly in India, pressured pricing all year. The global average moved lower quarter after quarter, driven mainly by intensifying generic competition, ample key-intermediate availability, and steady formulation capacity growth. China saw the steepest decline of the four. Europe's drop was the smallest, largely because its regulatory compliance costs offered a partial offset to the broader downward pressure elsewhere.
India's pregabalin price eroded from about USD 42.00/kg in Q1 2025 to USD 38.20/kg by Q4 - a 9.0% decline - as expanding domestic generic manufacturing capacity and intensifying price competition among formulators pressured the market all year. Key intermediate availability stayed ample for most of the year, reinforcing the downward drift, before early signs of Chinese supply tightness showed up toward year-end.
China posted the steepest annual drop of the four regions - from about USD 38.50/kg in Q1 2025 to USD 34.30/kg by Q4, down 10.9% - as ample intermediate production capacity and firm export competition from Indian formulators pressured pricing throughout the year. That decline ended abruptly in the closing weeks of 2025 once an environmental-compliance shutdown at a key intermediate producer began tightening feedstock availability.
US prices declined from about USD 58.00/kg in Q1 2025 to USD 54.10/kg by Q4 - a 6.7% drop, the smallest of the four regions - as a comparatively well-supplied formulation base absorbed generic competition more gradually than elsewhere. Rising imported-intermediate costs late in the year started offsetting the downward pressure, setting up the recovery that followed in 2026.
European prices fell from about USD 62.00/kg in Q1 2025 to USD 57.90/kg by Q4 - down 6.6% - keeping Europe the highest-priced market tracked throughout 2025 even while prices declined. Sustained regulatory audit and quality-compliance costs provided a partial structural offset to the generic-competition pressure that weighed more heavily on the other three regions.
Expert Market Research: Your Source for Real-Time Pregabalin Price Intelligence
Expert Market Research keeps a continuous eye on pregabalin prices across every major producing and consuming region, pulling together key-intermediate cost data, regulatory compliance trends, and generic-formulation demand signals into one regularly updated picture of the market. We're not just telling you prices moved - we're explaining why. Our team can help procurement benchmark supplier quotes, plan purchases around where markets diverge, and build a defensible read on where this API is headed. Get in touch with Expert Market Research for pregabalin pricing data, bespoke market analysis, and procurement advisory built around your needs.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Pregabalin is an anticonvulsant and analgesic API used for neuropathic pain, fibromyalgia, epilepsy, and (in some markets) generalized anxiety disorder. It's a generic staple, made via chiral-resolution and cyanide-based synthesis intermediates.
Global average pricing stood at USD 50.35/kg in Q2 2026, up 5.8% from Q1. Prices ranged from USD 40.20/kg in China to USD 61.90/kg in Europe, with India at USD 41.50/kg and the US at USD 57.80/kg.
Prices reversed after four quarters of 2025 decline, rising from USD 46.13/kg in Q4 2025 to USD 47.60/kg in Q1 2026 and USD 50.35/kg in Q2. The pickup traced to an environmental-compliance shutdown at a key Chinese intermediate producer.
Prices eroded through 2025 as expanding Indian generic capacity and ample intermediates intensified competition. An early-2026 environmental shutdown at a major Chinese intermediate producer then removed feedstock, pushing prices sharply higher.
The global average is expected to land between USD 48.00 and USD 55.00/kg through 2026, with recovery likely continuing at a moderate pace. Chinese intermediate supply should stay constrained while the affected producer completes remediation.
Europe is priciest due to strict quality-audit and compliance costs; the US follows on imported-intermediate costs and steady demand. India and China are cheaper, though China has spiked recently on the intermediate-producer shutdown.
This report is refreshed monthly, incorporating the latest quarterly pricing, recalculated percentage changes, and an updated forecast. Contact the Expert Market Research team for real-time data between updates.
Key-intermediate availability matters most, since synthesis depends on a few specialised chiral-resolution and cyanide-based inputs. Generic capacity expansion in India and China, environmental-compliance enforcement, and regulatory audit costs also drive volatility.
India's large generic manufacturing base drives competitive pricing, while China hosts major intermediate and API producers, though the recent shutdown exposed concentration risk. European producers face higher compliance costs; US formulators rely on imports.
Track key-intermediate supply and environmental-compliance developments in India and China, and time purchases around this report's quarterly breakdowns. Benchmarking quotes and qualifying backup suppliers across regions further reduces risk.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.